Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries

BACKGROUND: Despite the increased utilisation of Managed Entry Agreements (MEAs), empirical studies assessing their impact on achieving better access to medicines remains scarce. In this study we evaluated the role of MEAs on enhancing availability of and timely access to a sample of oncology medici...

Descripción completa

Detalles Bibliográficos
Autores principales: Efthymiadou, Olina, Kanavos, Panos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392357/
https://www.ncbi.nlm.nih.gov/pubmed/35987627
http://dx.doi.org/10.1186/s12913-022-08437-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392357/
https://www.ncbi.nlm.nih.gov/pubmed/35987627
http://dx.doi.org/10.1186/s12913-022-08437-w

Ejemplares similares